Insurers Must Pay Pharma Co. Defense Costs In SEC Probe

By Ruben Castaneda · February 13, 2024, 8:38 PM EST

A drug development company formed by a merger is entitled to insurance payments for expenses it paid two of its former officers in connection with federal subpoenas because the insurer failed...

To view the full article, register now.


Case Information

Case Title

Amtrust International Underwriters DAC v. 180 Life Sciences Corp.

Case Number



California Northern

Nature of Suit


Date Filed

June 29, 2022